Amylyx Pharmaceuticals Inc (AMLX)
5.715
+0.08
(+1.33%)
USD |
NASDAQ |
Nov 04, 16:00
5.70
-0.02
(-0.26%)
After-Hours: 04:30
Amylyx Pharmaceuticals Total Liabilities (Quarterly): 70.85M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 70.85M |
| March 31, 2024 | 93.02M |
| December 31, 2023 | 84.02M |
| September 30, 2023 | 48.18M |
| June 30, 2023 | 67.22M |
| March 31, 2023 | 55.31M |
| December 31, 2022 | 50.85M |
| Date | Value |
|---|---|
| September 30, 2022 | 37.42M |
| June 30, 2022 | 32.45M |
| March 31, 2022 | 33.49M |
| December 31, 2021 | 256.78M |
| September 30, 2021 | 254.53M |
| December 31, 2020 | 80.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
32.45M
Minimum
Jun 2022
256.78M
Maximum
Dec 2021
89.61M
Average
67.22M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| PTC Therapeutics Inc | 2.897B |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 332.16M |
| Shareholders Equity (Quarterly) | 261.31M |
| Current Ratio | 4.662 |